Zdrowie i gospodarka · 16/05/2016

FDA Releases Guidance on Histopathology and Biomarker Qualification

The FDA has released a new guidance document to help industry professionals use histopathology and associated methodologies to support biomarker qualification, with a focus on nonclinical studies and rigorous evaluation of biomarker performance in relation to histopathologic changes.